AI Analysis AI Analysis of GNPX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GNPX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Monday for Genprex Inc.
(Updated on Jun 29, 2026)

Sell candidate since Mar 30, 2026 Loss -71.47%

The Genprex Inc. stock price gained 2.06% on the last trading day (Monday, 29th Jun 2026), rising from $0.495 to $0.505. During the last trading day the stock fluctuated 9.42% from a day low at $0.491 to a day high of $0.537. The price has fallen in 6 of the last 10 days and is down by -21.12% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 55 thousand more shares were traded than the day before. In total, 260 thousand shares were bought and sold for approximately $131.10 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -55.90% during the next 3 months and, with a 90% probability hold a price between $0.134 and $0.355 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GNPX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 15.91%. Further rise is indicated until a new top pivot has been found. Genprex Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Genprex Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.517 and $0.688. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Genprex Inc. stock

Genprex Inc. finds support from accumulated volume at $0.487 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0462 between high and low, or 9.42%. For the last week, the stock has had daily average volatility of 8.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GNPX) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Genprex Inc. to open at $0.511, and during the day (based on 14 day Average True Range), to move between $0.475 and $0.535, which gives a possible trading interval of +/-$0.0603 (+/-12.70%) up or down from last closing price. If Genprex Inc. takes out the full calculated possible swing range there will be an estimated 12.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.521 (3.17%) than the support at $0.487 (3.64%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Genprex Inc. stock A Buy?

Genprex Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.462 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 30, 2026 - $0.511 ( 1.16%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GNPX Performance

Trading levels for GNPX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.557 10.31%
R2 0.539 6.82%
R1 0.529 4.66%
Price 0.505
S1 0.493 -2.33%
S2 0.482 -4.49%
S3 0.465 -7.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.592 17.23%
R2 0.550 8.93%
R1 0.521 3.17%
Price 0.505
S1 0.487 -3.64%
S2 0.483 -4.28%
S3 0.436 -13.72%

FAQ

What is the symbol for Genprex Inc. Stock and on which exchange is it traded?
The symbol for Genprex Inc. is GNPX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Genprex Inc. Stock?
Genprex Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Genprex Inc. Stock?
Genprex Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genprex Inc. Stock.

What's the current price of Genprex Inc. Stock?
As of the end of day on the Jun 29, 2026, the price of an Genprex Inc. (GNPX) share was $0.505.

What is the 52-week high and low for Genprex Inc. Stock?
The 52-week high for Genprex Inc. Stock is $12.97 and the 52-week low is $0.140.

What is the market capitalization of Genprex Inc. Stock?
As of the Jun 29, 2026, the market capitalization of Genprex Inc. is 824.08K.

When is the next earnings date for Genprex Inc.?
The upcoming earnings date for Genprex Inc. is Sep 02, 2026.
Click to get the best stock tips daily for free!
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE